Association of Uteroglobin G38A Polymorphism with IgA Nephropathy: A Meta-Analysis
Yong Du,Qingqing Wu,Hua Liu,Li Yang,Zou QingLing,Ying Hu,Qin QiaoJing,Hongzhang Shen
DOI: https://doi.org/10.1053/j.ajkd.2006.03.048
IF: 11.072
2006-01-01
American Journal of Kidney Diseases
Abstract:Both uteroglobin knockout and antisense transgenic mice develop pathological and clinical features similar to immunoglobulin A (IgA) nephropathy. However, several association studies of uteroglobin G38A polymorphism and IgA nephropathy showed controversial findings. We used meta-analysis to assess the impact of the uteroglobin G38A polymorphism on susceptibility to and progression of IgA nephropathy. Six studies involving uteroglobin G38A genotyping of 930 patients with IgA nephropathy and 768 healthy controls were included. No significant publication bias was found (Egger’s linear regression, P = 0.763; 95% confidence interval [CI], −0.610 to 0.476). All control samples were in Hardy-Weinberg proportion. No association between the AA genotype and risk for IgA nephropathy relative to both other genotypes (odds ratio [OR], 1.05; 95% CI, 0.71 to 1.54) or A allele and risk for IgA nephropathy (OR, 0.96; 95% CI, 0.84 to 1.11) were shown in the total meta-analysis. In both Asian and European subgroups, the overall effect of the AA genotype and A allele also showed no significant difference. There also was no significant association between uteroglobin AA genotype or A allele and IgA nephropathy progression (OR, 3.62; 95% CI, 0.59 to 22.34; OR, 2.19, 95% CI, 0.37 to 13.14, respectively). We suggest that uteroglobin G38A polymorphism is not related to the development and progression of IgA nephropathy. Both uteroglobin knockout and antisense transgenic mice develop pathological and clinical features similar to immunoglobulin A (IgA) nephropathy. However, several association studies of uteroglobin G38A polymorphism and IgA nephropathy showed controversial findings. We used meta-analysis to assess the impact of the uteroglobin G38A polymorphism on susceptibility to and progression of IgA nephropathy. Six studies involving uteroglobin G38A genotyping of 930 patients with IgA nephropathy and 768 healthy controls were included. No significant publication bias was found (Egger’s linear regression, P = 0.763; 95% confidence interval [CI], −0.610 to 0.476). All control samples were in Hardy-Weinberg proportion. No association between the AA genotype and risk for IgA nephropathy relative to both other genotypes (odds ratio [OR], 1.05; 95% CI, 0.71 to 1.54) or A allele and risk for IgA nephropathy (OR, 0.96; 95% CI, 0.84 to 1.11) were shown in the total meta-analysis. In both Asian and European subgroups, the overall effect of the AA genotype and A allele also showed no significant difference. There also was no significant association between uteroglobin AA genotype or A allele and IgA nephropathy progression (OR, 3.62; 95% CI, 0.59 to 22.34; OR, 2.19, 95% CI, 0.37 to 13.14, respectively). We suggest that uteroglobin G38A polymorphism is not related to the development and progression of IgA nephropathy. IMMUNOGLOBULIN A (IgA) nephropathy is the most common glomerulonephritis in the world. Details of the mechanism of this disease are not clear to date; however, recent studies showed gene variants associated with the susceptibility, clinical presence, and progression of this disease.1Donadio J.V. Grande J.P. IgA nephropathy.N Engl J Med. 2002; 347: 738-748Crossref PubMed Scopus (673) Google Scholar, 2Hsu S.I. Ramirez S.B. Winn M.P. Bonventre J.V. Owen W.F. Evidence for genetic factors in the development and progression of IgA nephropathy.Kidney Int. 2000; 57: 1818-1835Crossref PubMed Scopus (155) Google Scholar Uteroglobin, also named Clara cell protein (CCD10), is a steroid-inducible, cytokine-like, multifunctional protein with anti-inflammatory and immunomodulatory functions.3Mukherjee A.B. Kundu G.C. Mantile-Selvaggi G. et al.Uteroglobin A novel cytokine?.Cell Mol Life Sci. 1999; 55: 771-787Crossref PubMed Scopus (120) Google Scholar It has high affinity for fibronectin (Fn) and forms Fn-uteroglobin heterodimers, which counteract the Fn-collagen interactions required for abnormal deposition in some diseases. Both gene knockout and antitransgenic mice developed clinical and pathological features similar to human IgA nephropathy.4Zhang Z. Kundu G.C. Yuan C.J. et al.Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin.Science. 1997; 276: 1408-1412Crossref PubMed Scopus (117) Google Scholar, 5Zhang Z. Kundu G.C. Zheng F. et al.Insight into the physiological function(s) of uteroglobin by gene-knockout and antisense-transgenic approaches.Ann N Y Acad Sci. 2000; 923: 210-233Crossref PubMed Scopus (22) Google Scholar, 6Pouria S. Challacombe S.J. Uteroglobin deficient mice—A novel animal model for IgA nephropathy?.Gut. 2000; 46: 452-453Crossref PubMed Scopus (1) Google Scholar, 7Zheng F. Kundu G.C. Zhang Z. Ward J. DeMayo F. Mukherjee A.B. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.Nat Med. 1999; 5: 1018-1025Crossref PubMed Scopus (90) Google Scholar Therefore, uteroglobin is considered an important candidate gene for IgA nephropathy. However, in human IgA nephropathy, Coppo et al8Coppo R. Chiesa M. Cirina P. Peruzzi L. Amore A. European IgACE Study GroupIn human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice.Am J Kidney Dis. 2002; 40: 495-503Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar found that uteroglobin did not have the role inferred from transgenic mice. Association studies testing the uteroglobin G38A polymorphism with IgA nephropathy also produced inconsistent results, even in the same ethnic groups.9Szelestei T. Bahring S. Kovacs T. et al.Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy.Am J Kidney Dis. 2000; 36: 468-473Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar, 10Kim Y.S. Kang D. Kwon D.Y. et al.Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression.Pharmacogenetics. 2001; 11: 299-305Crossref PubMed Scopus (46) Google Scholar, 11Matsunaga A. Numakura C. Kawakami T. et al.Association of the uteroglobin gene polymorphism with IgA nephropathy.Am J Kidney Dis. 2002; 39: 36-41Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar, 12Narita I. Saito N. Goto S. et al.Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.Kidney Int. 2002; 61: 1853-1858Crossref PubMed Scopus (38) Google Scholar, 13Menegatti E. Nardacchione A. Alpa M. et al.Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy.Lab Invest. 2002; 82: 543-546Crossref PubMed Scopus (29) Google Scholar, 14Lu J.C. Zhang H. Chen Y.Q. Liu G. Wang H.Y. Uteroglobin G38A polymorphism is associated with the progression of IgA nephropathy in Chinese patients.Zhonghua Nei Ke Za Zhi. 2004; 43: 37-40PubMed Google Scholar Meta-analysis is a powerful tool for summarizing results from different studies by producing a single estimate of the major effect with enhanced precision. One of the major advantages of meta-analysis is to increase sample size, which may decrease the probability that random error will produce false-positive or false-negative associations.15Lee Y.H. Harley J.B. Nath S.K. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE) A meta-analysis.Hum Genet. 2005; 116: 361-367Crossref PubMed Scopus (109) Google Scholar Here, we use meta-analysis to clarify the association of uteroglobin G38A polymorphism with IgA nephropathy. We performed the meta-analysis from May 2005. All studies that investigated the association of the uteroglobin G38A polymorphism with IgA nephropathy published before this time were considered in the meta-analysis. Studies were identified by using extended computer-based searches of the PubMed database and Cochrane library. References in MEDLINE-cited studies were reviewed to identify additional reports not indexed by MEDLINE. The following key words and subject terms were searched: Uteroglobin, blastokinin, progesterone-binding protein, Clara cell protein, polychlorinated biphenyl–binding protein, retinol-binding protein, IgA nephropathy, and polymorphism, without language restriction. Only data from full published reports were used. From each study, the following information was extracted: first author, journal, year of publication, racial descent of study population, demographics, matching, validity of the genotyping method, and numbers of cases and controls for each uteroglobin G38A genotype. Frequencies of alleles were calculated for cases and controls from the corresponding genotype distributions. To assess publication bias, we evaluated study quality by using a funnel plot. We constructed a funnel plot of effect size against its SE. The funnel plot should be asymmetric when there is publication bias and symmetric in the case of no publication bias. Because the funnel plot approach is limited by the requirement for a range of studies with varying size, we used Egger’s linear regression test.16Egger M. Davey Smith G. Schneider M. Minder C. Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997; 315: 629-634Crossref PubMed Scopus (33707) Google Scholar Egger’s test measures the funnel plot asymmetry on the natural logarithm scale of the odds ratio (OR). Chi-square test was used to determine whether observed frequencies of genotypes conformed to Hardy-Weinberg expectations. We used Review Manager 4.2 software (The Cochrane Collaboration, Oxford, UK) for the meta-analysis. First, within-study and between-study variation or heterogeneity was tested by using Cochran Q statistic. If a significant Q statistic (P < 0.05) indicated heterogeneity across studies, the random-effects model was used for meta-analysis. Otherwise, the fixed-effect model was used. Six relevant studies concerning the uteroglobin G38A polymorphism and IgA nephropathy were identified initially through a MEDLINE search and reference review. These 6 studies encompassed 2 European and 4 Asian subject collections9Szelestei T. Bahring S. Kovacs T. et al.Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy.Am J Kidney Dis. 2000; 36: 468-473Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar, 10Kim Y.S. Kang D. Kwon D.Y. et al.Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression.Pharmacogenetics. 2001; 11: 299-305Crossref PubMed Scopus (46) Google Scholar, 11Matsunaga A. Numakura C. Kawakami T. et al.Association of the uteroglobin gene polymorphism with IgA nephropathy.Am J Kidney Dis. 2002; 39: 36-41Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar, 12Narita I. Saito N. Goto S. et al.Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.Kidney Int. 2002; 61: 1853-1858Crossref PubMed Scopus (38) Google Scholar (Table 1).Table 1Characteristics of Individual Studies of Uteroglobin G38A Polymorphism With IgA NephropathyReferenceYearRacial DescentDistribution of Uteroglobin G38A GenotypeDistribution of Uteroglobin G38A AllelesAAGAGGAGIgA NephropathyControlIgA NephropathyControlIgA NephropathyControlIgA NephropathyControlIgA NephropathyControlSzelestei et al9Szelestei T. Bahring S. Kovacs T. et al.Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy.Am J Kidney Dis. 2000; 36: 468-473Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar2000Caucasian812544748457071150137Menegatti et al13Menegatti E. Nardacchione A. Alpa M. et al.Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy.Lab Invest. 2002; 82: 543-546Crossref PubMed Scopus (29) Google Scholar2002Caucasian3531182756628889130151Kim et al10Kim Y.S. Kang D. Kwon D.Y. et al.Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression.Pharmacogenetics. 2001; 11: 299-305Crossref PubMed Scopus (46) Google Scholar2001Korean2313563532121026112059Narita et al12Narita I. Saito N. Goto S. et al.Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.Kidney Int. 2002; 61: 1853-1858Crossref PubMed Scopus (38) Google Scholar2002Japanese4332109958769195159283233Matsunaga et al11Matsunaga A. Numakura C. Kawakami T. et al.Association of the uteroglobin gene polymorphism with IgA nephropathy.Am J Kidney Dis. 2002; 39: 36-41Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar2002Japanese1517236923575310369183Lu et al14Lu J.C. Zhang H. Chen Y.Q. Liu G. Wang H.Y. Uteroglobin G38A polymorphism is associated with the progression of IgA nephropathy in Chinese patients.Zhonghua Nei Ke Za Zhi. 2004; 43: 37-40PubMed Google Scholar2004Chinese4029170809036250138350152 Open table in a new tab All studies used polymerase chain reaction–restriction fragment length polymorphism to genotype the uteroglobin G38A polymorphism, but only 4 studies used directing sequence to confirm results of polymerase chain reaction–restriction fragment length polymorphism. Hardy-Weinberg test showed that all genotype and allele frequencies in the control populations had the expected Hardy-Weinberg proportions. Findings of these 6 studies were very controversial. Only 1 study of a Japanese population found that this polymorphic site was associated significantly with the development of IgA nephropathy, whereas the other studies found no association. Five studies investigated the impact of the uteroglobin G38A polymorphism on IgA nephropathy progression. Three of these studies suggested that the AA genotype strongly affected the prognosis of IgA nephropathy in Japanese, Chinese, and Caucasian populations. However, 2 other studies by Narita et al10Kim Y.S. Kang D. Kwon D.Y. et al.Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression.Pharmacogenetics. 2001; 11: 299-305Crossref PubMed Scopus (46) Google Scholar of a Japanese population and Kim et al12Narita I. Saito N. Goto S. et al.Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.Kidney Int. 2002; 61: 1853-1858Crossref PubMed Scopus (38) Google Scholar of a Korean group suggested that patients with the GG genotype had poorer outcomes than those with other genotypes. The study included a total of 930 patients with IgA nephropathy and 768 healthy controls. In the IgA nephropathy group, allele G was the most frequent: 59.2% (95% confidence interval [CI], 57.0 to 61.4), whereas A allele frequency was 40.8% (95% CI, 38.6 to 43.0). In the control group, the prevalence of allele G was 54.4% (95% CI, 51.9 to 56.9), and the prevalence of allele A was 45.6% (95% CI, 43.1 to 48.1). Prevalences of AA in patients with IgA nephropathy and controls were 17.6% (95% CI, 15.2 to 20.0) and 17.4% (95% CI, 15.0 to 19.8), respectively. Prevalences of GG homozygotes in patients with IgA nephropathy and controls were 36.1% (95% CI, 33.0 to 39.2) and 36.6% (95% CI, 33.2 to 40.0), respectively. Prevalences of GA heterozygotes in patients with IgA nephropathy and controls were 46.3% (95% CI, 43.0 to 49.5) and 46.0% (95% CI, 42.5 to 49.5), respectively. Publication bias was assessed graphically by using funnel plots and assessed statistically by using Egger’s test. There was no evidence of publication bias among studies in this meta-analysis (Egger’s regression test, t = −0.319; P = 0.730; 95% CI, −0.610 to 0.476; Fig 1). There also was no heterogeneity across all 6 studies (heterogeneity Q test, v = 5; P = 0.06). Consequently, the fixed-effect model was selected. Overall OR for the AA genotype was 1.03 (95% CI, 0.79 to 1.34; Z = 0.22; P = 0.82; Fig 2). For the A allele, there is no heterogeneity among the 6 studies and overall OR was 0.96 (95% CI, 0.84 to 1.11; Z = 0.52; P = 0.60; Fig 2).Fig 2Association between uteroglobin G38A and the development of IgA nephropathy in all studies: (A) AA versus AG + GG genotype and (B) A versus G allele. Aggregate OR, 95% CI of risk genotype, and risk allele also are given, along with the probability of heterogeneity of Cochran Q test. The weighting factor (weight %) used to calculate the aggregate OR, calculated from the inverse of the variance, is given for each study.View Large Image Figure ViewerDownload (PPT) To evaluate the race-specific effect, we divided the population according to ethnicity. There was significant heterogeneity among the 4 studies in Asian groups for genotype distribution (heterogeneity Q test, v = 3; P = 0.04). As a result, the random-effect model was selected. Overall OR for the AA genotype in Asian groups was 1.08 (95% CI, 0.63 to 1.82; Z = 0.27; P = 0.79); for the A allele, it was 0.94 (95% CI, 0.80 to 1.11; Z = 0.72; P = 0.47 in the fixed-effect model; Table 2). For the European group, significant association of the AA genotype or A allele and risk for IgA nephropathy also was not found (Table 2). These results show that neither the AA genotype nor A allele had a role in risk for IgA nephropathy.Table 2Meta-Analysis of Uteroglobin G38A Polymorphism and IgA Nephropathy Association in Ethnic SubgroupsPolymorphic SitesEthnic GroupNo. of StudiesSample SizeTest of HeterogeneityTest of AssociationIgA NephropathyControlPModelZPOR (95% CI)GenotypeAsian47115440.04Random0.270.791.08 (0.63-1.82)European22192240.14Fixed0.320.751.08 (0.67-1.76)AlleleAsian47115440.17Fixed0.720.470.94 (0.80-1.11)European22192240.39Fixed0.180.861.03 (0.78-1.35) Open table in a new tab Figure 3 shows the meta-analysis of the association between the uteroglobin G38A polymorphism and deteriorating renal function in patients with IgA nephropathy. Five studies reported their results on the association of uteroglobin polymorphism and IgA nephropathy progression. Of these, Narita et al12Narita I. Saito N. Goto S. et al.Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.Kidney Int. 2002; 61: 1853-1858Crossref PubMed Scopus (38) Google Scholar found that the uteroglobin genotype did not significantly affect the prognosis of renal function in all patients by means of univariate analysis (GG versus GA/AA; P = 0.24), but in a subgroup with hypertension or heavy proteinuria, renal survival of patients with the GG genotype was poorer than that of patients with the other genotypes. Because of data limitation, this study was excluded from the analysis of progression, and only 4 other studies were involved. Of these 4 studies, Lu et al14Lu J.C. Zhang H. Chen Y.Q. Liu G. Wang H.Y. Uteroglobin G38A polymorphism is associated with the progression of IgA nephropathy in Chinese patients.Zhonghua Nei Ke Za Zhi. 2004; 43: 37-40PubMed Google Scholar did not give detailed data about allele distribution. Therefore, we performed the association of uteroglobin genotype and IgA nephropathy progression with 4 studies, whereas for allele, just 3 studies were included. There was significant heterogeneity among these 4 studies; thus, the random-effect method was used. The overall effect of AA genotype was 3.62 (95% CI, 0.59 to 22.34; Z = 1.38; P = 0.17); for A allele, the OR of 2.19 also did not reach statistical significance (P = 0.39). This indicates no relation between the AA genotype or A allele and IgA nephropathy progression. Predisposition to such complex diseases as IgA nephropathy probably is affected by a variety of genetic and environmental factors. It now is realized that genetic risk factors for complex diseases should be assessed cautiously and, if possible, by using large-scale evidence.17Ioannidis J.P.A. Trikalinos T.A. Ntzani E.E. Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies An empirical assessment.Lancet. 2003; 361: 567-571Abstract Full Text Full Text PDF PubMed Scopus (503) Google Scholar In the present study, we used meta-analysis to evaluate the association of uteroglobin G38A polymorphism with IgA nephropathy. Our findings suggest that uteroglobin G38A polymorphism is not related to susceptibility for and progression of IgA nephropathy. Several studies focusing on the association of uteroglobin G38A polymorphism with IgA nephropathy had controversial conclusions. The lack of concordance across many of these studies reflects both small sample sizes and method limitations, such as population stratification. Many other methods, such as genomic control18Schulze T.G. McMahon F.J. Genetic association mapping at the crossroads Which test and why? Overview and practical guidelines.Am J Med Genet. 2002; 114: 1-11Crossref PubMed Scopus (84) Google Scholar, 19Devlin B. Roeder K. Wasserman L. Genomic control, a new approach to genetic-based association studies.Theor Popul Biol. 2001; 60: 155-166Crossref PubMed Scopus (397) Google Scholar and family-based study,20Spielman R.S. McGinnis R.E. Ewens W.J. Transmission test for linkage disequilibrium The insulin gene region and insulin-dependent diabetes mellitus (IDDM).Am J Hum Genet. 1993; 52: 506-516PubMed Google Scholar, 21Li Y.J. Du Y. Li C.X. et al.Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3′ untranslated region of the Megsin gene.J Am Soc Nephrol. 2004; 15: 1739-1743Crossref PubMed Scopus (42) Google Scholar were approached for resolving this problem. Meta-analysis can summarize results from different studies by producing a single estimate of the major effect with enhanced precision. Therefore, a comprehensive meta-analysis may assist in estimating population-wide effects of genetic risk factors in human disease and provide more reliable results than a single case-control study.22Ioannidis J.P. Ntzani E.E. Trikalinos T.A. Contopoulos-Ioannidis D.G. Replication validity of genetic association studies.Nat Genet. 2001; 29: 306-309Crossref PubMed Scopus (1620) Google Scholar Our meta-analysis did not find a significant association between the development of IgA nephropathy and AA risk genotype and A allele of uteroglobin G38A. In the entire study, overall OR for the AA genotype was 1.05; for the A allele, overall OR was 0.96, both without significant differences (Fig 2). In ethnic subgroups, significant heterogeneity was found across the 4 Asian studies; thus, the random-effect model was selected. Overall OR for the uteroglobin AA genotype and A allele in the Asian group showed no significant differences (P = 0.79 and P = 0.49, respectively; Table 2). Similarly, we also found no association in the European group for the AA genotype and A allele (P = 0.75 and P = 0.86, respectively; Table 2). These results indicate that the uteroglobin G38A polymorphism is not associated with susceptibility to IgA nephropathy. Meta-analysis of the association of the uteroglobin G38A polymorphism with IgA progression is shown in Fig 3. There was significant heterogeneity for both the AA genotype and A allele; therefore, the random-effect model was selected. Overall ORs for the AA genotype and A allele had no statistical significance (P = 0.17 and P = 0.39, respectively). It means that the uteroglobin G38A polymorphism did not influence the progression of IgA nephropathy. Details of the mechanism of the lack of association between the uteroglobin G38A polymorphism and IgA nephropathy are unclear. In animal models, in vitro studies showed that uteroglobin could bind Fn and IgA-Fn complex, which further prevents glomerular deposition of multimeric Fn and collagen.3Mukherjee A.B. Kundu G.C. Mantile-Selvaggi G. et al.Uteroglobin A novel cytokine?.Cell Mol Life Sci. 1999; 55: 771-787Crossref PubMed Scopus (120) Google Scholar, 7Zheng F. Kundu G.C. Zhang Z. Ward J. DeMayo F. Mukherjee A.B. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.Nat Med. 1999; 5: 1018-1025Crossref PubMed Scopus (90) Google Scholar In vivo, uteroglobin-deficient mice developed pathological and clinical features similar to IgA nephropathy.4Zhang Z. Kundu G.C. Yuan C.J. et al.Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin.Science. 1997; 276: 1408-1412Crossref PubMed Scopus (117) Google Scholar, 5Zhang Z. Kundu G.C. Zheng F. et al.Insight into the physiological function(s) of uteroglobin by gene-knockout and antisense-transgenic approaches.Ann N Y Acad Sci. 2000; 923: 210-233Crossref PubMed Scopus (22) Google Scholar, 6Pouria S. Challacombe S.J. Uteroglobin deficient mice—A novel animal model for IgA nephropathy?.Gut. 2000; 46: 452-453Crossref PubMed Scopus (1) Google Scholar, 7Zheng F. Kundu G.C. Zhang Z. Ward J. DeMayo F. Mukherjee A.B. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.Nat Med. 1999; 5: 1018-1025Crossref PubMed Scopus (90) Google Scholar However, in human IgA nephropathy, uteroglobin is not decreased in circulation and is even increased in IgA-Fn complexes.8Coppo R. Chiesa M. Cirina P. Peruzzi L. Amore A. European IgACE Study GroupIn human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice.Am J Kidney Dis. 2002; 40: 495-503Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar It was speculated that uteroglobin might have a role of an anti-inflammatory protein in human IgA nephropathy because its upregulation might be switched on to decrease the amount of macromolecular aggregates containing Fn and aberrantly glycosylated IgA1 complexed with antigens, lectins, IgG, and complement factors.8Coppo R. Chiesa M. Cirina P. Peruzzi L. Amore A. European IgACE Study GroupIn human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice.Am J Kidney Dis. 2002; 40: 495-503Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar, 23Coppo R. Emancipator S.N. Pathogenesis of IgA nephropathy Established observations, new insights and perspective in treatment.J Nephrol. 1994; 7: 5-15Google Scholar Additional studies are needed to elucidate the different roles of uteroglobin in humans. As is often the case with meta-analyses, we also realized several limitations in our study. First, the conclusion is based on a relatively small number of studies and participants. Second, controls were not screened consistently across studies to exclude subclinical latent IgA nephropathy. Third, because of data limitation, we cannot perform additional analyses in different clinical subgroups, such as comparison of patients with and without hypertension. Finally, there was very significant heterogeneity (P < 0.0001) among these studies involved in the analysis of progression. Undoubtedly, this should affect our final conclusion. In brief, this meta-analysis shows no significant association between IgA nephropathy and the uteroglobin G38A polymorphic site. Our findings suggest that additional research on uteroglobin gene variance and IgA nephropathy is warranted in genetically homogeneous populations, and the genotype-phenotype relationship between uteroglobin and IgA nephropathy also needs additional studies. More importantly, for IgA nephropathy, a multifactorial disease with several major susceptibility loci, the sample size required to replicate a linkage or association study to a specific locus should be larger than in previous studies.24Schena F.P. D’Altei C. Cerullo G. Manno C. Gesualdo L. ACE gene polymorphism and IgA nephropathy An ethnically homogeneous study and a meta-analysis.Kidney Int. 2001; 60: 732-740Crossref PubMed Scopus (76) Google Scholar